Ashley, D. L., Bonin, M. A., Hamar, B. & McGeehin, M. (1996) Using the blood concentration of 2,5-dimethylfuran as a marker for smoking. Int Arch. Occup. Environ Health 68: 183-187.

Baker, R. R., Dixon, M., Mariner, D. C., Shepperd, C. J., Scherer, G., Ogden, M. W., Robinson, J. H., Sinclair, N. M., Sherwood, N., Akiyama, Y., Sakamoto, K., Röper, W., Tricker, A. R., Marchand, V., Varignon, B. & Lionetti, G. (2004a) Terms used for exposure to smoke. Beitr. Tabakforsch. Int. 21: 250.

Baker, T. B., Brandon, T. H. & Chassin, L. (2004b) Motivational influences on cigarette smoking. Annu. Rev. Psychol. 55: 463-491.

Balint, B., et al. "Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke." Thorax 56.6 (2001): 456-61.

Benowitz, N. L. (1999) Biomarkers of environmental tobacco smoke exposure. Environ. Health Perspect. 107 Suppl 2: 349-355.

Benowitz, N. L. (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18: 188-204.

Benowitz, N. L., Jacob, I. P., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., Hurt, R. D. & Velicer, W. (2002) Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4: 149-159.

Bliss, R. E. & O'Connell, K. A. (1984) Problems with thiocyanate as an index of smoking status: a critical review with suggestions for improving the usefulness of biochemical measures in smoking cessation research. Health Psychol. 3: 563-581.

Boettcher, M. I. & Angerer, J. (2005) Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS [in press]. J Chromatogr B in press

Boogaard, P. J. & van Sittert, N. J. (1995) Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occup. Environ Med. 52: 611-620.

Borgerding, M. & Klus, H. (2005) Analysis of complex mixtures--cigarette smoke. Exp Toxicol Pathol. 57 Suppl 1: 43-73.

Bowman, D. L., Smith, C. J., Bombick, B. R., Avalos, J. T., Davis, R. A., Morgan, W. T. & Doolittle, D. J. (2002) Relationship between FTC 'tar' and urine mutagenicity in smokers of tobacco-burning or Eclipse cigarettes. Mutat. Res. 521: 137-149.

Bramer, S. L. & Kallungal, B. A. (2003) Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 8: 187-203.

Breland, A. B., Acosta, M. C. & Eissenberg, T. (2003) Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance(TM). Tob. Control 12: 317-321.

Breland, A. B., Buchhalter, A. R., Evans, S. E. & Eissenberg, T. (2002a) Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine. Tob. Res. 4 Suppl 2: S131-S140.

Breland, A. B., Evans, S. E., Buchhalter, A. R. & Eissenberg, T. (2002b) Acute effects of Advance: a potential reduced exposure product for smokers. Tob. Control 11: 376-378.

Bryant, M. S., Vineis, P., Skipper, P. L. & Tannenbaum, S. R. (1988) Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc. Natl. Acad. Sci. U. S. A. 85: 9788-9791.

Buchhalter, A. R. & Eissenberg, T. (2000) Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine. Tob. Res. 2: 39-43.

Byrd, G. D., Davis, R. A. & Ogden, M. W. (2005) A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. J Chromatogr Sci 43: 133-140.

Byrd, G. D. & Ogden, M. W. (2003) Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine. J Mass Spectrom. 38: 98-107.

Carmella, S. G., Akerkar, S. A., Richie, J. P., Jr. & Hecht, S. S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomarkers Prev. 4: 635-642.

Carmella, S. G., Chen, M., Villalta, P. W., Gurney, J. G., Hatsukami, D. K. & Hecht, S. S. (2002) Ethylation and methylation of hemoglobin in smokers and non-smokers. Carcinogenesis 23: 1903-1910.

Carmella, S. G., Han, S., Fristad, A., Yang, Y. & Hecht, S. S. (2003) Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol. Biomarkers Prev. 12: 1257-1261.

Carmella, S. G., Le, K. A. & Hecht, S. S. (2004) Improved method for determination of 1-hydroxypyrene in human urine. Cancer Epidemiol. Biomarkers Prev. 13: 1261-1264.

Counts, M. E., Morton, M. J., Laffoon, S. W., Cox, R. H. & Lipowicz, P. J. (2005) Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol Pharmacol 41: 185-227.

Cunnington, A. J. & Hormbrey, P. (2002) Breath analysis to detect recent exposure to carbon monoxide. Postgrad. Med. J 78: 233-237.

Curvall, M., Romert, L., Norlen, E. & Enzell, C. R. (1987) Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users--a comparison. Mutat. Res. 188: 105-110.

Dhar, P. (2004) Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. J. Pharm. Biomed. Anal. 35: 155-168.

Djordjevic, M. V., Stellman, S. D. & Zang, E. (2000) Doses of nicotine and lung carcinogens delivered to cigarette smokers. J. Natl. Cancer Inst. 92: 106-111.

Dor, F., Dab, W., Empereur-Bissonnet, P. & Zmirou, D. (1999) Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Crit Rev Toxicol 29: 129-168.

ECLIPSE Expert Panel (2000) A safer cigarette? A comparative study. A consensus report. Inhal. Toxicol. 12: 1-48.

Farmer, P. B., Brown, K., Tompkins, E., Emms, V. L., Jones, D. J., Singh, R. & Phillips, D. H. (2005a) DNA adducts: Mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 207: 293-301.

Farmer, P. B., Kaur, B., Roach, J., Levy, L., Consonni, D., Bertazzi, P. A., Pesatori, A., Fustinoni, S., Buratti, M., Bonzini, M., Colombi, A., Popov, T., Cavallo, D., Desideri, A., Valerio, F., Pala, M., Bolognesi, C. & Merlo, F. (2005b) The use of S-phenylmercapturic acid as a biomarker in molecular epidemiology studies of benzene. Chem. Biol. Interact. 153-154: 97-102.

Fennell, T. R., MacNeela, J. P., Morris, R. W., Watson, M., Thompson, C. L. & Bell, D. A. (2000) Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9: 705-712.

Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H. & Hecht, S. S. (1991) Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol 4: 364-368.

Fustinoni, S., Soleo, L., Warholm, M., Begemann, P., Rannug, A., Neumann, H. G., Swenberg, J. A., Vimercati, L. & Colombi, A. (2002) Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11: 1082-1090.

Glatz, Z., Novakova, S. & Sterbova, H. (2001) Analysis of thiocyanate in biological fluids by capillary zone electrophoresis. J Chromatogr A 916: 273-277.

Gündel, J. & Angerer, J. (2000) High-performance liquid chromatographic method with fluorescence detection for the determination of 3-hydroxybenzo[a]pyrene and 3-hydroxybenz[a]anthracene in the urine of polycyclic aromatic hydrocarbon-exposed workers. J Chromatogr B Biomed. Sci Appl 738: 47-55.

Hagmar, L., Wirfalt, E., Paulsson, B. & Tornqvist, M. (2005) Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat. Res 580: 157-165.

Hatsukami, D. (2005) Hope or Hazard? What Research Tells us About "Potentially Reduced-Exposure" Tobacco Products. Minneapolis, MN: University of Minnesota Transdisiplinary Tobacco Use Research Center

Hatsukami, D. K., Giovino, G. A., Eissenberg, T., Clark, P. I., Lawrence, D. & Leischow, S. (2005) Methods to assess potential reduced exposure products. Nicotine Tob Res 7: 827-844.

Hatsukami, D. K., Hecht, S. S., Hennrikus, D. J., Joseph, A. M. & Pentel, P. R. (2003) Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota. Nicotine Tob. Res. 5: 387-396.

Hatsukami, D. K., Henningfield, J. E. & Kotlyar, M. (2004a) Harm reduction approaches to reducing tobacco-related mortality. Annu. Rev. Public Health 25: 377-395.

Hatsukami, D. K., Lemmonds, C., Zhang, Y., Murphy, S. E., Le, C., Carmella, S. G. & Hecht, S. S. (2004b) Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl. Cancer Inst. 96: 844-852.

Hecht, S. S. (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23: 907-922.

Hecht, S. S. (2004) Tobacco smoke carcinogens: human uptake and DNA interactions. In: Tobacco and Public Health: Science and Policy. (Boyle, P., Gray, N., Henningfield, J., Seffrin, J. & Zatonski, W., eds.). Oxford, UK: Oxford University Press, pp. 93-125.

Hecht, S. S., Carmella, S. G., Le, K. A., Murphy, S. E., Li, Y. S., Le, C., Jensen, J. & Hatsukami, D. K. (2004a) Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. Cancer Epidemiol. Biomarkers Prev. 13: 834-842.

Hecht, S. S., Carmella, S. G., Ye, M., Le, K. A., Jensen, J. A., Zimmerman, C. L. & Hatsukami, D. K. (2002) Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res 62: 129-134.

Hecht, S. S., Murphy, S. E., Carmella, S. G., Li, S., Jensen, J., Le, C., Joseph, A. M. & Hatsukami, D. K. (2005) Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol. Biomarkers Prev. 14: 693-698.

Hecht, S. S., Murphy, S. E., Carmella, S. G., Zimmerman, C. L., Losey, L., Kramarczuk, I., Roe, M. R., Puumala, S. S., Li, Y. S., Le, C., Jensen, J. & Hatsukami, D. K. (2004b) Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J. Natl. Cancer Inst. 96: 107-115.

Hecht, S. S., Ye, M., Carmella, S. G., Fredrickson, A., Adgate, J. L., Greaves, I. A., Church, T. R., Ryan, A. D., Mongin, S. J. & Sexton, K. (2001) Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol. Biomarkers Prev. 10: 1109-1116.

Henn, S. A., Succop, P., Talaska, G., Anderson, K., Hecht, S. S. & Gross, M. (2004) Carcinogen-DNA adducts are increased int he exfoliated urothelial cells of wives of smokers: biological monitoring of passive smoke exposure. Polycycl Aromat Comp 24: 475-485.

Horvath, I., Hunt, J. & Barnes, P. J. (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J 26: 523-548.

Houeto, P., Hoffman, J. R., Got, P., Dang, V. B. & Baud, F. J. (1997) Acetonitrile as a possible marker of current cigarette smoking. Hum. Exp. Toxicol. 16: 658-661.

Hughes, J. R. (2000) Reduced smoking: an introduction and review of the evidence. Addiction 95 Suppl 1: S3-S7.

Hughes, J. R., Hecht, S. S., Carmella, S. G., Murphy, S. E. & Callas, P. (2004) Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni. Tob. Control 13: 175-179.

Hughes, J. R. & Keely, J. P. (2004) The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure. Nicotine Tob Res 6: 1021-1027.

Hurt, R. D., Croghan, G. A., Wolter, T. D., Croghan, I. T., Offord, K. P., Williams, G. M., Djordjevic, M. V., Richie, J. P., Jr. & Jeffrey, A. M. (2000) Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine. Tob. Res. 2: 327-336.

Institute of Medicine (2001) Clearing the Smoke. Assessing the Science Base for Tobacco Harm Reduction. (Stratton, K., Shetty, P., Wallace, R. & Bondurant, S., eds. ). Washington, DC: National Academy Press.

International Conference on Harmonisation. "ICH Harmonised Tripartite Guidelines: Validation of analytical procedures: methodology." Aug. 5, 2005. 1996. http://www.nihs.go.jp/dig/ich/quality/q2b/q2bstep4.pdf.

Jaakkola, M. S. & Jaakkola, J. J. (1997) Assessment of exposure to environmental tobacco smoke. Eur. Respir. J 10: 2384-2397.

Jacob, J., Grimmer, G. & Dettbarn, G. (1999) Profile of urinary phenanthrene metabolites in smokers and non-smokers. Biomarkers 4: 319-327.

Jacob, J. & Seidel, A. (2002) Biomonitoring of polycyclic aromatic hydrocarbons in human urine. J Chromatogr B Analyt. Technol. Biomed. Life Sci 778: 31-47.

Jacob, P., III, Hatsukami, D., Severson, H., Hall, S., Yu, L. & Benowitz, N. L. (2002) Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol. Biomarkers Prev. 11: 1668-1673.

Jacob, P., III, Yu, L., Liang, G., Shulgin, A. T. & Benowitz, N. L. (1993) Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J. Chromatogr. 619: 49-61.

Jacob, P., III, Yu, L., Shulgin, A. T. & Benowitz, N. L. (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am. J. Public Health 89: 731-736.

Jarup, L., Berglund, M., Elinder, C. G., Nordberg, G. & Vahter, M. (1998) Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand. J Work Environ Health 24 Suppl 1: 1-51.

Jarup, L., Rogenfelt, A., Elinder, C. G., Nogawa, K. & Kjellstrom, T. (1983) Biological half-time of cadmium in the blood of workers after cessation of exposure. Scand. J Work Environ Health 9: 327-331.

Jarvis, M. J. (2004) Why people smoke. BMJ 328: 277-279.

Jarvis, M. J., Boreham, R., Primatesta, P., Feyerabend, C. & Bryant, A. (2001) Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J. Natl. Cancer Inst. 93: 134-138.

Jarvis, M. J., Primatesta, P., Erens, B., Feyerabend, C. & Bryant, A. (2003) Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob. Res. 5: 349-355. NV#29 NV#28

Jenkins, R. A., Maskarinec, M. P., Counts, R. W., Caton, J. E., Tomkins, B. A. & Ilgner, R. H. (2001) Environmental tobacco smoke in an unrestricted smoking workplace: area and personal exposure monitoring. J Expo. Anal. Environ Epidemiol. 11: 369-380.

Jongeneelen, F. J. (2001) Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann. Occup. Hyg. 45: 3-13.

Jordan, A., Hansel, A., Holzinger, R. & Lindinger, W. (1995) Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS). Int J Mass Spectrometry and Ion Processes 148: L1-L3.

Kharitonov, S. A., Robbins, R. A., Yates, D., Keatings, V. & Barnes, P. J. (1995) Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am. J. Respir. Crit Care Med. 152: 609-612.

Lirk, P., Bodrogi, F., Deibl, M., Kahler, C. M., Colvin, J., Moser, B., Pinggera, G., Raifer, H., Rieder, J. & Schobersberger, W. (2004) Quantification of recent smoking behaviour using proton transfer reaction-mass spectrometry (PTR-MS). Wien. Klin. Wochenschr. 116: 21-25.

Kim, H., Kim, Y. D., Lee, H., Kawamoto, T., Yang, M. & Katoh, T. (1999) Assay of 2-naphthol in human urine by high-performance liquid chromatography. J Chromatogr B Biomed. Sci Appl 734: 211-217.

Lee, B. L., Ong, H. Y., Ong, Y. B. & Ong, C. N. (2005) A sensitive liquid chromatographic method for the spectrophotometric determination of urinary trans,trans-muconic acid. J Chromatogr B Analyt. Technol. Biomed. Life Sci 818: 277-283.

Lee, E. M., Malson, J. L., Waters, A. J., Moolchan, E. T. & Pickworth, W. B. (2003) Smoking topography: reliability and validity in dependent smokers. Nicotine Tob. Res. 5: 673-679.

Lee, P. N. & Forey, B. A. (2003) Why are lung cancer rate trends so different in the United States and United kingdom? Inhal. Toxicol. 15: 909-949.

Mascher, D. G., Mascher, H. J., Scherer, G. & Schmid, E. R. (2001) High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J Chromatogr B Biomed. Sci Appl 750: 163-169.

McKee, H. C., Rhoades, J. W., Campbell, J. & Gross, A. L. (1962) Acetonitrile in body fluids related to smoking. Public Health Rep 77: 553-554.

Melikian, A. A., Prahalad, A. K. & Hoffmann, D. (1993) Urinary trans,trans-muconic acid as an indicator of exposure to benzene in cigarette smokers. Cancer Epidemiol. Biomarkers Prev. 2: 47-51.

Merlo, F., Andreassen, A., Weston, A., Pan, C. F., Haugen, A., Valerio, F., Reggiardo, G., Fontana, V., Garte, S., Puntoni, R. & Abbondandolo, A. (1998) Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7: 147-155.

Michaelis, H. C., Clemens, C., Kijewski, H., Neurath, H. & Eggert, A. (1991) Acetonitrile serum concentrations and cyanide blood levels in a case of suicidal oral acetonitrile ingestion. J. Toxicol. Clin. Toxicol. 29: 447-458.

Montuschi, P. & Barnes, P. J. (2002) Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol. Sci. 23: 232-237.

Mooney, L. A., Santella, R. M., Covey, L., Jeffrey, A. M., Bigbee, W., Randall, M. C., Cooper, T. B., Ottman, R., Tsai, W. Y. & Wazneh, L. (1995) Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomarkers Prev. 4: 627-634.

Murphy, S. E., Link, C. A., Jensen, J., Le, C., Puumala, S. S., Hecht, S. S., Carmella, S. G., Losey, L. & Hatsukami, D. K. (2004) A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol. Biomarkers Prev. 13: 1617-1623.

Muscat, J. E., Djordjevic, M. V., Colosimo, S., Stellman, S. D. & Richie, J. P., Jr. (2005) Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 103: 1420-1426.

Nan, H. M., Kim, H., Lim, H. S., Choi, J. K., Kawamoto, T., Kang, J. W., Lee, C. H., Kim, Y. D. & Kwon, E. H. (2001) Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis 22: 787-793.

National Institutes of Health, N. C. I. (2001) Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Smoking and Control Monograph No. 13. (Burns, D. M., Benowitz, N. L. & Amacher, R. H., eds. ). NIH Pub. No. 02-5074. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Jenkins, R. A., Maskarinec, M. P., Counts, R. W., Caton, J. E., Tomkins, B. A. & Ilgner, R. H. (2001) Environmental tobacco smoke in an unrestricted smoking workplace: area and personal exposure monitoring. J Expo. Anal. Environ Epidemiol. 11: 369-380.

Jongeneelen, F. J. (2001) Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann. Occup. Hyg. 45: 3-13.

Jordan, A., Hansel, A., Holzinger, R. & Lindinger, W. (1995) Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS). Int J Mass Spectrometry and Ion Processes 148: L1-L3.

Kim, H., Kim, Y. D., Lee, H., Kawamoto, T., Yang, M. & Katoh, T. (1999) Assay of 2-naphthol in human urine by high-performance liquid chromatography. J Chromatogr B Biomed. Sci Appl 734: 211-217.

Lee, B. L., Ong, H. Y., Ong, Y. B. & Ong, C. N. (2005) A sensitive liquid chromatographic method for the spectrophotometric determination of urinary trans,trans-muconic acid. J Chromatogr B Analyt. Technol. Biomed. Life Sci 818: 277-283.

Lee, E. M., Malson, J. L., Waters, A. J., Moolchan, E. T. & Pickworth, W. B. (2003) Smoking topography: reliability and validity in dependent smokers. Nicotine Tob. Res. 5: 673-679.

Lee, P. N. & Forey, B. A. (2003) Why are lung cancer rate trends so different in the United States and United kingdom? Inhal. Toxicol. 15: 909-949.

Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G., Hyland, A., Sweanor, D. & Warner, K. E. (2004) The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol. Biomarkers Prev. 13: 2035-2042.

Li, H., Krieger, R. I. & Li, Q. X. (2000) Improved HPLC method for analysis of 1-hydroxypyrene in human urine specimens of cigarette smokers. Sci Total Environ 257: 147-153.

Lirk, P., Bodrogi, F., Deibl, M., Kahler, C. M., Colvin, J., Moser, B., Pinggera, G., Raifer, H., Rieder, J. & Schobersberger, W. (2004) Quantification of recent smoking behaviour using proton transfer reaction-mass spectrometry (PTR-MS). Wien. Klin. Wochenschr. 116: 21-25.

Mascher, D. G., Mascher, H. J., Scherer, G. & Schmid, E. R. (2001) High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J Chromatogr B Biomed. Sci Appl 750: 163-169.

McKee, H. C., Rhoades, J. W., Campbell, J. & Gross, A. L. (1962) Acetonitrile in body fluids related to smoking. Public Health Rep 77: 553-554.

Melikian, A. A., Prahalad, A. K. & Hoffmann, D. (1993) Urinary trans,trans-muconic acid as an indicator of exposure to benzene in cigarette smokers. Cancer Epidemiol. Biomarkers Prev. 2: 47-51.

Merlo, F., Andreassen, A., Weston, A., Pan, C. F., Haugen, A., Valerio, F., Reggiardo, G., Fontana, V., Garte, S., Puntoni, R. & Abbondandolo, A. (1998) Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7: 147-155.

Michaelis, H. C., Clemens, C., Kijewski, H., Neurath, H. & Eggert, A. (1991) Acetonitrile serum concentrations and cyanide blood levels in a case of suicidal oral acetonitrile ingestion. J. Toxicol. Clin. Toxicol. 29: 447-458.

Murphy, S. E., Link, C. A., Jensen, J., Le, C., Puumala, S. S., Hecht, S. S., Carmella, S. G., Losey, L. & Hatsukami, D. K. (2004) A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol. Biomarkers Prev. 13: 1617-1623.

Muscat, J. E., Djordjevic, M. V., Colosimo, S., Stellman, S. D. & Richie, J. P., Jr. (2005) Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 103: 1420-1426.

Nan, H. M., Kim, H., Lim, H. S., Choi, J. K., Kawamoto, T., Kang, J. W., Lee, C. H., Kim, Y. D. & Kwon, E. H. (2001) Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis 22: 787-793.

National Institutes of Health, N. C. I. (2001) Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Smoking and Control Monograph No. 13. (Burns, D. M., Benowitz, N. L. & Amacher, R. H., eds. ). NIH Pub. No. 02-5074. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

North Carolina Agricultural Research Service. Smokeless Tobacco Research Products. 2005. 9-29-2005.

Ong, C. N., Lee, B. L., Shi, C. Y., Ong, H. Y. & Lee, H. P. (1994) Elevated levels of benzene-related compounds in the urine of cigarette smokers. Int. J. Cancer 59: 177-180.

Patskan, G. & Reininghaus, W. (2003) Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary of findings. J. Appl. Toxicol. 23: 323-328.

Pavanello, S., Simioli, P., Carrieri, M., Gregorio, P. & Clonfero, E. (2002) Tobacco-smoke exposure indicators and urinary mutagenicity. Mutat. Res. 521: 1-9.

Perbellini, L., Princivalle, A., Cerpelloni, M., Pasini, F. & Brugnone, F. (2003) Comparison of breath, blood and urine concentrations in the biomonitoring of environmental exposure to 1,3-butadiene, 2,5-dimethylfuran, and benzene. Int. Arch. Occup. Environ Health 76: 461-466.

Phillips, D. H. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23: 1979-2004.

Phillips, D. H. (2005) DNA adducts as markers of exposure and risk. Mutat. Res 577: 284-292.

Phillips, D. H., Hewer, A. & Arlt, V. M. (2005) 32P-Postlabeling Analysis of DNA Adducts. Methods Mol. Biol. 291: 3-12.

Pinggera, G. M., Lirk, P., Bodogri, F., Herwig, R., Steckel-Berger, G., Bartsch, G. & Rieder, J. (2005) Urinary acetonitrile concentrations correlate with recent smoking behaviour. BJU. Int 95: 306-309.

Poirier, M. C., Santella, R. M. & Weston, A. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21: 353-359.

Richter, E. & Branner, B. (2002) Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B Analyt. Technol. Biomed. Life Sci 778: 49-62.

Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G. & Mehta, J. L. (2004) Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109: IV6-19.

Robbins, R. A., et al. "Smoking cessation is associated with an increase in exhaled nitric oxide." Chest 112.2 (1997): 313-18.

Satarug, S., Ujjin, P., Vanavanitkun, Y., Nishijo, M., Baker, J. R. & Moore, M. R. (2004) Effects of cigarette smoking and exposure to cadmium and lead on phenotypic variability of hepatic CYP2A6 and renal function biomarkers in men. Toxicology 204: 161-173.

Scherer, G. (1998) Smoking behaviour and compensation: An evaluation of the literature. Available at http://legacy.library.ucsf.edu/tid/poi13e00. Accessed 12-6-2002.

Scherer, G. (2005) Biomonitoring of inhaled complex mixtures--ambient air, diesel exhaust and cigarette smoke. Exp Toxicol Pathol. 57 Suppl 1: 75-110.

Scherer, G., Doolittle, D. J., Ruppert, T., Meger-Kossien, I., Riedel, K., Tricker, A. R. & Adlkofer, F. (1996) Urinary mutagenicity and thioethers in nonsmokers: role of environmental tobacco smoke (ETS) and diet. Mutat. Res. 368: 195-204.

Scherer, G., Krause, G., Mascher, D., & Schmid, E. (2000) Biological monitoring of the tobacco smoke-related exposure to acrolein. Available at http://legacy.library.ucsf.edu/tid/eol66c00. Accessed 8-29-0005.

Scherer, G., Renner, T. & Meger, M. (1998) Analysis and evaluation of trans,trans-muconic acid as a biomarker for benzene exposure. J Chromatogr B Biomed. Sci Appl 717: 179-199.

Schettgen, T., Broding, H. C., Angerer, J. & Drexler, H. (2002) Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol Lett. 134: 65-70.

Shields, P. G. (2002) Tobacco smoking, harm reduction, and biomarkers. J. Natl. Cancer Inst. 94: 1435-1444.

Smith, C. J., Guy, T. D., Stiles, M. F., Morton, M. J., Collie, B. B., Ingebrethsen, B. J. & Robinson, J. H. (1998) A repeatable method for determination of carboxyhemoglobin levels in smokers. Hum. Exp. Toxicol 17: 29-34.

Smith, C. J., McKarns, S. C., Davis, R. A., Livingston, S. D., Bombick, B. R., Avalos, J. T., Morgan, W. T. & Doolittle, D. J. (1996) Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat. Res. 361: 1-9.

Spira, A., Beane, J., Shah, V., Liu, G., Schembri, F., Yang, X., Palma, J. & Brody, J. S. (2004) Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl. Acad. Sci. U. S. A. 101: 10143-10148.

Stabbert, R., Voncken, P., Rustemeier, K., Haussmann, H. J., Roemer, E., Schaffernicht, H. & Patskan, G. (2003) Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke. J. Appl. Toxicol. 23: 329-339.

Stepanov, I. & Hecht, S. S. (2005) Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol. Biomarkers Prev. 14: 885-891.

Talaska, G., Schamer, M., Skipper, P., Tannenbaum, S., Caporaso, N., Unruh, L., Kadlubar, F. F., Bartsch, H., Malaveille, C. & Vineis, P. (1991) Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1: 61-66.

Teague, S. V., Pinkerton, K. E., Goldsmith, M., Gebremichael, A., Chang, S., Jenkins, R. A. & Moneyhun, J. H. (1994) Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal. Toxicol. 6: 79-93.

Telisman, S., Jurasovic, J., Pizent, A. & Cvitkovic, P. (1997) Cadmium in the blood and seminal fluid of nonoccupationally exposed adult male subjects with regard to smoking habits. Int Arch. Occup. Environ Health 70: 243-248.

Tulunay, O. E., Hecht, S. S., Carmella, S. G., Zhang, Y., Lemmonds, C., Murphy, S. & Hatsukami, D. K. (2005) Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers. Cancer Epidemiol. Biomarkers Prev. 14: 1283-1286.

U.S.Food and Drug Administration. (2001) Guidance for Industry. Bioanalytical Method Validation. Available at http://www.fda.gov/cder/guidance/4252fnl.pdf. Accessed 7-13-2005.

Urban, M., Gilch, G., Schepers, G., van, M. E. & Scherer, G. (2003) Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt. Technol. Biomed. Life Sci 796: 131-140.

van Doorn R., Bos, R. P., Leijdekkers, C. M., Wagenaas-Zegers, M. A., Theuws, J. L. & Henderson, P. T. (1979) Thioether concentration and mutagenicity of urine from cigarette smokers. Int Arch. Occup. Environ Health 43: 159-166.

van Leeuwen, D. M., et al. "Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents." Toxicol Sci 86.1 (2005): 200-10.

Van Rooij, J. G., Veeger, M. M., Bodelier-Bade, M. M., Scheepers, P. T. & Jongeneelen, F. J. (1994) Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources

van Sittert, N. J., Megens, H. J. J. J., Watson, W. P. & Boogaard, P. J. (2000) Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol Sci. 56: 189-202.

Vineis, P., Airoldi, L., Veglia, F., Oligiati, L., Pastorelli, R., Autrup, H., Dunning, A., Garte, S., Gormally, E., Hainaut, P., Malaveille, C., Matullo, G., Peluso, M., Overvad, K., Tjonneland, A., C, avel-Chapelon, F., Boeing, H., Krogh, V., Palli, D., Panico, S., Tumino, R., Bueno-De-Mesquita, B., Peeters, P., Berglund, G., Hallmans, G., Saracco, R. & Riboli, E. (2005) Environmental tobacco smoke and risk of respiratory cancer and chronic obstuctive pulmonary disease in former smokers and never smokers in the EPIC prospective study[Online version]. Br. Med. J. Online-In Press

Wald, N. J., Idle, M., Boreham, J. & Bailey, A. (1981) Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 36: 366-369.

World Health Organization (2004) Involuntary Smoking. 1. Composition, exposure and regulations. In: IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Volume 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: International Agency for Cancer Research, pp. 1191-1230.

Yang, M., Koga, M., Katoh, T. & Kawamoto, T. (1999) A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Arch. Environ Contam Toxicol 36: 99-108.

The June, 2005 issue of the newsletter of the Centre de Coopération pour les Recherches Scientifiques Relatives au Tabac (CORESTA).

Scope of Work for the Population Effects and Behavior Committee

Scope of Work for the Biological Effects Assessment Committee